Addington, J. & Addington, D. (1998). Effect of substance misuse in early psychosis. British Journal of Psychiatry, 172(Suppl.), 134–6.Google Scholar

Basu, D., Malhotra, A., Bhagat, A., & Varma, V. K. (1999). Cannabis psychosis and acute schizophrenia. European Addiction Research, 5, 71–3.Google Scholar

Benabud, A. (1957). Psychopathological aspects of the cannabis situation in Morocco: Statistical data for 1956. Bulletin on Narcotics, 9(2), 143.Google Scholar

Berk, M., Brook, S., & Trandafir, A. I. (1999). A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: A double-blind randomized controlled trial. International Clinical Psychopharmacology, 14(3), 177–80.Google Scholar

Bowers, M. B. & Hoffman, F. J. (1986). Regional brain homovanillic acid following delta9-tetrahydrocannabinol and cocaine. Brain Research, 366, 405–7.Google Scholar

Bowers, M. B., Imirowicz, R., Druss, B., & Mazure, C. M. (1995). Autonomous psychosis following psychotogenic substance abuse. Biological Psychiatry, 147, 1164–7.Google Scholar

Campbell, A. M. G., Thomson, J. L. G., Evans, M. & Willians, M. J. (1972). Cerebral atrophy in young cannabis smokers. Lancet, 1 (7743), 202–3.Google Scholar

Cantwell, R., Brewin, J., Glazebrook, C., et al. (1999). Prevalence of substance misuse in first-episode psychosis. British Journal of Psychiatry, 174, 150–53.Google Scholar

Caspi, A., Moffit, T. E., Cannon, M., et al. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-o-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biological Psychiatry, 57(10), 1117–27.Google Scholar

Chambers, R. A., Krystal, J. H., & Self, D. W. (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry, 50, 71–83.Google Scholar

Chaudry, H. R., Moss, H. B., Bashir, A., & Suliman, T. (1991). Cannabis psychosis following bhang ingestion. British Journal of Addiction, 86, 1075–81.Google Scholar

Chopra, G. S. & Smith, J. W. (1974). Psychotic reactions following cannabis use in East Indians. Archives of General Psychiatry, 30, 24–7.Google Scholar

Cuesta, M., Peralta, V., & Caro, F. (1999). Premorbid personality in psychoses. Schizophrenia Bulletin, 25(4), 801–11.Google Scholar

D'Souza, D. C., Cho, H.-S., Perry, E. B., & Krystal, J. H. (2004). Cannabinoid “model ” psychosis, dopamine-cannabinoid interactions and implications for schizophrenia. In Castle, D. & Murray, R., eds., Marijuana and Madness. Cambridge: Cambridge University Press pp. 142–65.

Emrich, H. M., Leweke, F. M., & Schneider, U. (1997). Towards a cannabinoid hypothesis of schizophrenia: Cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacology, Biochemistery and Behavior, 56, 803–7.Google Scholar

Fergusson, D. M., Horwood, L. J., & Swain-Campbell, N. R. (2003). Cannabis dependence and psychotic symptoms in young people. Psychological Medicine, 33, 15–21.Google Scholar

Ghodse, A. H. (1986). Cannabis psychosis. British Journal of Addictions, 81, 473–8.Google Scholar

González, S., Bisogno, T., Wenger, T., et al. (2000). Sex steroid influence on cannabinoid receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochemical and Biophysical Research Communications, 270, 260–66.Google Scholar

Green, A. I., Zimmet, S. V., Strous, R. D., & Schildkraut, J. J. (1999). Clozapine for comorbid substance use disorder and schizophrenia: Do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?Harvard Review of Psychiatry, 6, 287–96.Google Scholar

Hall, W. & Degenhardt, L. (2004). Is there a specific “cannabis psychosis”? In Castle, D. & Murray, R., eds., Marijuana and Madness. Cambridge: Cambridge University Press, pp. 89–100.

Hart, R. (1976). A psychiatric classification of cannabis intoxication. Journal of the American Academy of Psychiatry and Neurology, 1, 83–97.Google Scholar

Kalivas, P. W., Pierce, R. C., & Sorg, B. A. (2000). Sensitivity role in paranoia and stimulants-induced psychoses. In Palomo, T., Beninger, R. J., Jiménez-Arriero, M. A., Archer, & T., eds., Schizopsychotic Disorders. Madrid: Fundación Cerebro y Mente, pp. 85–94.

Kendler, K. S. & Prescott, C. A. (1998). Cannabis use, abuse, and dependence in a population-based sample of female twins. American Journal of Psychiatry, 155(8), 1016–22.Google Scholar

Keup, W. (1970). Psychotic symptoms due to cannabis abuse. Diseases of the Nervous System, 2, 119–25.Google Scholar

Krebs, M.-O., Leroy, S., Devaux, E., et al. (2002). Vulnerability to cannabis, schizophrenia and the (ATT) N polymorphism of the cannabinoid receptor type I (CMRJ) gene. Schizophrenia Research, 53(Suppl. 3), 72.Google Scholar

Leweke, F. M. & Emrich, H. M. (1999). Carbamazapine as an adjunct in the treatment of schizophrenia-like psychosis related to cannabis abuse. International Clinical Psychopharmacology, 14(1), 37–9.Google Scholar

Leweke, F. M., Giuffrida, A., Wurster, U., Emrich, H. M., & Piomelli, D. (1999). Elevated endogenous canniboids in schizophrenia. NeuroReport, 10, 1665–9.Google Scholar

Loeber, R. T. & Yurgelun-Todd, D. A. (1999). Human neuroimaging of acute and chronic marijuana use: Implications for frontocerebellar dysfunction. Human Psychopharmacology Clinical and Experimental, 14, 291–301.Google Scholar

Longhurst, J. G. & Boutros, N. N. (1997). Cannabis-induced chronic psychosis: An underacknowledged disorder?Australian and New Zealand Journal of Psychiatry, 31(2), 304–5.Google Scholar

Lundqvist, T., Jönsson, S., & Warkentin, S. (2001). Frontal lobe dysfunction in long-term cannabis users. Neurotoxicology and Teratology, 23, 437–443.Google Scholar

Mathers, D. C. & Ghodse, A. H. (1992). Cannabis and psychotic illness. British Journal of Psychiatry, 161, 648–53.Google Scholar

Maykut, M. O. (1985). Health consequences of acute and chronic marihuana use. Progress in Neuropsychopharmacological and Biological Psychiatry, 9, 209–38.Google Scholar

McBride, A. J. & Thomas, H. (1995). Psychosis is also common in users of “normal” cannabis. British Medical Journal, 311, 875.Google Scholar

McGuire, P. K., Jones, P., Harvey, I., et al. (1994). Cannabis and acute schizophrenia. Schizophrenia Research, 13, 161–8.Google Scholar

McGuire, P. K., Jones, P., Harvey, I.et al. (1995). Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophrenia Research, 15, 277–81.Google Scholar

Mendhiratta, S. S., Wing, N. N., & Verma, S. K. (1978). Some psychological correlates of long-term, heavy cannabis users. British Journal of Psychiatry, 132, 482–6.Google Scholar

Miller, P., Lawrie, S. M., Hodges, A., et al. (2001). Genetic liability, illicit drug use. Life stress and psychotic symptoms: Preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 36, 338–42.Google Scholar

Murray, R. M., O'Callaghan, E., Castle, D. J., & Lewis, S. W. (1992). A neurodevelopmental approach to the classification of schizophrenia. Schizophrenia Bulletin, 18, 319–32.Google Scholar

Negrete, J. C. (1983). Human effects of cannabinoids. Acta Psiquiátrica y Psicológica de América Latina, 29, 267–76.Google Scholar

Negrete, J. C. (1984). Clinical psychiatric complications of cannabis use: An update. Marihuana 84 Proceedings of the Oxford Symposium on Cannabis. September, Oxford, pp. 581–92.

Núñez Domínguez, L. A. & Gurpegui, M. (1997). Cannabis psychosis: A five year follow-up study. International Meeting on Interactive Monoaminergic Brain Disorders. October 8–12, P3.5, p. 76.

Núñez Domínguez, L. A. & Gurpegui, Fernández de Legaria, M. (2002). Cannabis-induced psychosis: A cross-sectional comparison with acute schizophrenia. Acta Psychiatrica Scandinavica, 105(3), 173–9.Google Scholar

Pälsson, A., Thulin, S. O., & Tunving, K. (1982). Cannabis psychoses in South Sweden. Acta Psychiatrica Scandinavica, 66, 311–21.Google Scholar

Phillips, L. J., Curry, C., Yung, A. R., et al. (2002). Cannabis use is not associated with the development of psychosis in an “ultra” high-risk group. Australian and New Zealand Journal of Psychiatry, 36(6), 800–6.Google Scholar

Pistis, M., Perra, S., Pilolla, G., et al. (2004). Adolescent exposure to cannabinoids induces long-lasting changes in the response to drug of abuse of rat midbrain dopamine neurons. Biological Psychiatry, 56, 86–94.Google Scholar

Poole, R. & Brabbins, C. (1996). Drug induced psychosis. British Journal of Psychiatry, 168, 135–8.Google Scholar

Preti, A. & Miotto, P. (2000). Increase in first admissions for schizophrenia and other major psychosis in Italy. Psychiatry Research, 94, 139–52.Google Scholar

Rodríguez de Fonseca, F., Gorriti, M., Bilbao, A., et al. (2001). Role of the endogenous cannabinoid system as a modulator of dopamine transmission: Implications for Parkinson's disease and schizophrenia. Neurotoxicity Research, 3, 23–35.Google Scholar

Rolfe, M., Tang, C. M., Sabally, S., et al. (1993). Psychosis and cannabis abuse in The Gambia. British Journal of Psychiatry, 163, 798–801.Google Scholar

Rottanburg, D., Ben-Arie, O., Robins, A. H., Teggin, A., & Elk, R. (1982). Cannabis-associated psychosis with hypomaniac features. Lancet, 2, 1364–6.Google Scholar

Sato, M. (1992). A lasting vulnerability to psychosis in patients with previous metamphetamine psychosis. Annals of the New York Academy of Sciences, 654, 160–70.Google Scholar

Siever, L. J. & Davis, K. L. (1991). A psychobiological perspective of the personality disorders. American Journal of Psychiatry, 148, 1647–58.Google Scholar

Stefanis, N. C., Delespaul, P., Henquest, C., et al. (2004). Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction, 99, 1333–41.Google Scholar

Struve, F. A., Straumanis, J. J., & Patrick, G. (1994). Persistent topographic quantitative EEG sequelae of chronic marihuana use. A replication study and initial discriminant function analysis. Clinical Electroencephalography, 25, 63–75.Google Scholar

Talbott, J. A. & Teague, J. W. (1969). Marihuana psychoses: Acute toxic psychosis associated with the use of cannabis derivatives. Journal of American Medical Association, 210, 296–302.Google Scholar

Tennant, F. S. & Groesbeck, C. J. (1972). Psychiatric effects of hashish. Archives of General Psychiatry, 27, 133–6.Google Scholar

Thacore, V. R. & Shukla, S. R. P. (1976). Cannabis psychosis and paranoid schizophrenia. Archives of General Psychiatry, 33, 383–6.Google Scholar

Thomas, H. (1993). Psychiatric symptoms in cannabis users. British Journal of Psychiatry, 163, 141–9.Google Scholar

Thornicroft, G. (1990). Cannabis and psychosis. Is there epidemiological evidence for an association?British Journal of Psychiatry, 157, 25–33.Google Scholar

Thornicroft, G., Meadows, G., & Politi, P. (1992). Is “cannabis psychosis” a distinct category?European Psychiatry, 7, 277–82.Google Scholar

Tsapakis, E.-M., Guillin, O., & Murray, R. M. (2003). Does dopamine sensitization underlie the association between schizophrenia and drug abuse?Current Opinion in Psychiatry, 16(Suppl. 2), S45–52.Google Scholar

Tsuang, M. T., Simpson, J. C., & Kronfold, Z. (1982). Subtypes of drug abuse with psychosis. Archives of General Psychiatry, 39, 141–7.Google Scholar

Ujike, H. (2002). Stimulant-induced psychosis and schizophrenia: The role of sensitization. Current Psychiatric Reports, 4, 177–84.Google Scholar

Ujike, H., Takaki, M., Nakata, K., et al. (2002). CNR1 central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Molecular Psychiatry, 7, 515–18.Google Scholar

Os, J., Bak, M., Hanssen, M., Graaf, R., & Verdoux, H. (2002). Cannabis use and psychosis: A longitudinal population-based study. American Journal of Epidemiology, 156(4), 319–27.Google Scholar

Verdoux, H., Sorbara, F., Gindre, C., Swendsen, J., & Os, J. (2002). Cannabis use and dimensions of psychosis in a nonclinical population of female subjects. Schizophrenia Research, 59, 77–84.Google Scholar

Vorugatti, L. N. P., Slomska, P., Zabel, P., Mattar, A., & Awad, A. G. (2001). Cannabis-induced dopamine release: An in-vivo SPECT study. Psychiatric Research, 107, 173–7.Google Scholar

Williams, J. H., Wellman, N. A., & Rawlins, J. N. P. (1996). Cannabis use correlates with schizotypy in healthy people. Addiction, 91, 869–77.Google Scholar

Wilson, W. H. & Mathews, R. J. (2002). Effects of marijuana on brain: Function and structure. In Onaivi, E. S., ed., Biology of Marijuana: From Gene to Behavior.New York: Taylor & Francis, pp. 234–72.